Arcturus Therapeutics Holdings Inc. (ARCT): Price and Financial Metrics
Arcturus Therapeutics Holdings Inc. (ARCT)
Today's Latest Price: $40.09 USD
Updated Sep 25 4:00pm
Add ARCT to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 233 in Medical - Pharmaceuticals
See all "A" rated Strong Buy stocks
ARCT Stock Summary
- With a one year PEG ratio of 0.17, Arcturus Therapeutics Holdings Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than only 4.16% of US stocks.
- ARCT's price/sales ratio is 86.88; that's higher than the P/S ratio of 97.01% of US stocks.
- As for revenue growth, note that ARCT's revenue has grown -45.87% over the past 12 months; that beats the revenue growth of only 4.56% of US companies in our set.
- Stocks with similar financial metrics, market capitalization, and price volatility to Arcturus Therapeutics Holdings Inc are LOGC, EVGN, ORMP, CRIS, and PULM.
- Visit ARCT's SEC page to see the company's official filings. To visit the company's web site, go to www.arcturusrx.com.
ARCT Stock Price Chart Technical Analysis Charts
ARCT Price/Volume Stats
| Current price | $40.09 | 52-week high | $66.24 |
| Prev. close | $37.49 | 52-week low | $8.51 |
| Day low | $37.12 | Volume | 420,859 |
| Day high | $40.84 | Avg. volume | 584,771 |
| 50-day MA | $49.93 | Dividend yield | N/A |
| 200-day MA | $30.86 | Market Cap | 977.71M |
Arcturus Therapeutics Holdings Inc. (ARCT) Company Bio
Arcturus Therapeutics Ltd a biopharmaceutical company, focuses on the development and commercialization of oral drug candidates. The company was founded in 2008 and is based in Tel Aviv, Israel.
Loading social stream, please wait...